Budesonide Commercial Medicine Market, Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Budesonide Commercial Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Budesonide Commercial Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Budesonide Commercial Medicine Overall Market Size
2.1 Global Budesonide Commercial Medicine Market Size: 2021 VS 2028
2.2 Global Budesonide Commercial Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Budesonide Commercial Medicine Players in Global Market
3.2 Top Global Budesonide Commercial Medicine Companies Ranked by Revenue
3.3 Global Budesonide Commercial Medicine Revenue by Companies
3.4 Top 3 and Top 5 Budesonide Commercial Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Budesonide Commercial Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Budesonide Commercial Medicine Players in Global Market
3.6.1 List of Global Tier 1 Budesonide Commercial Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Budesonide Commercial Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Budesonide Commercial Medicine Market Size Markets, 2021 & 2028
4.1.2 Injectable Suspension
4.1.3 Aerosols
4.1.4 Inhalation Powder
4.1.5 Tablet and Capsule
4.2 By Type - Global Budesonide Commercial Medicine Revenue & Forecasts
4.2.1 By Type - Global Budesonide Commercial Medicine Revenue, 2017-2022
4.2.2 By Type - Global Budesonide Commercial Medicine Revenue, 2023-2028
4.2.3 By Type - Global Budesonide Commercial Medicine Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Budesonide Commercial Medicine Market Size, 2021 & 2028
5.1.2 Respiratory Disease Treatment
5.1.3 Nose Disease Treatment
5.1.4 Inflammatory Bowel Disease Treatment
5.1.5 Others
5.2 By Application - Global Budesonide Commercial Medicine Revenue & Forecasts
5.2.1 By Application - Global Budesonide Commercial Medicine Revenue, 2017-2022
5.2.2 By Application - Global Budesonide Commercial Medicine Revenue, 2023-2028
5.2.3 By Application - Global Budesonide Commercial Medicine Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Budesonide Commercial Medicine Market Size, 2021 & 2028
6.2 By Region - Global Budesonide Commercial Medicine Revenue & Forecasts
6.2.1 By Region - Global Budesonide Commercial Medicine Revenue, 2017-2022
6.2.2 By Region - Global Budesonide Commercial Medicine Revenue, 2023-2028
6.2.3 By Region - Global Budesonide Commercial Medicine Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Budesonide Commercial Medicine Revenue, 2017-2028
6.3.2 US Budesonide Commercial Medicine Market Size, 2017-2028
6.3.3 Canada Budesonide Commercial Medicine Market Size, 2017-2028
6.3.4 Mexico Budesonide Commercial Medicine Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Budesonide Commercial Medicine Revenue, 2017-2028
6.4.2 Germany Budesonide Commercial Medicine Market Size, 2017-2028
6.4.3 France Budesonide Commercial Medicine Market Size, 2017-2028
6.4.4 U.K. Budesonide Commercial Medicine Market Size, 2017-2028
6.4.5 Italy Budesonide Commercial Medicine Market Size, 2017-2028
6.4.6 Russia Budesonide Commercial Medicine Market Size, 2017-2028
6.4.7 Nordic Countries Budesonide Commercial Medicine Market Size, 2017-2028
6.4.8 Benelux Budesonide Commercial Medicine Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Budesonide Commercial Medicine Revenue, 2017-2028
6.5.2 China Budesonide Commercial Medicine Market Size, 2017-2028
6.5.3 Japan Budesonide Commercial Medicine Market Size, 2017-2028
6.5.4 South Korea Budesonide Commercial Medicine Market Size, 2017-2028
6.5.5 Southeast Asia Budesonide Commercial Medicine Market Size, 2017-2028
6.5.6 India Budesonide Commercial Medicine Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Budesonide Commercial Medicine Revenue, 2017-2028
6.6.2 Brazil Budesonide Commercial Medicine Market Size, 2017-2028
6.6.3 Argentina Budesonide Commercial Medicine Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Budesonide Commercial Medicine Revenue, 2017-2028
6.7.2 Turkey Budesonide Commercial Medicine Market Size, 2017-2028
6.7.3 Israel Budesonide Commercial Medicine Market Size, 2017-2028
6.7.4 Saudi Arabia Budesonide Commercial Medicine Market Size, 2017-2028
6.7.5 UAE Budesonide Commercial Medicine Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Budesonide Commercial Medicine Major Product Offerings
7.1.4 AstraZeneca Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Teva
7.2.1 Teva Corporate Summary
7.2.2 Teva Business Overview
7.2.3 Teva Budesonide Commercial Medicine Major Product Offerings
7.2.4 Teva Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.2.5 Teva Key News
7.3 Mylan
7.3.1 Mylan Corporate Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Budesonide Commercial Medicine Major Product Offerings
7.3.4 Mylan Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.3.5 Mylan Key News
7.4 Sandoz
7.4.1 Sandoz Corporate Summary
7.4.2 Sandoz Business Overview
7.4.3 Sandoz Budesonide Commercial Medicine Major Product Offerings
7.4.4 Sandoz Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.4.5 Sandoz Key News
7.5 Cosmo Pharmaceuticals
7.5.1 Cosmo Pharmaceuticals Corporate Summary
7.5.2 Cosmo Pharmaceuticals Business Overview
7.5.3 Cosmo Pharmaceuticals Budesonide Commercial Medicine Major Product Offerings
7.5.4 Cosmo Pharmaceuticals Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.5.5 Cosmo Pharmaceuticals Key News
7.6 Salix
7.6.1 Salix Corporate Summary
7.6.2 Salix Business Overview
7.6.3 Salix Budesonide Commercial Medicine Major Product Offerings
7.6.4 Salix Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.6.5 Salix Key News
7.7 Chiesi Farmaceutici
7.7.1 Chiesi Farmaceutici Corporate Summary
7.7.2 Chiesi Farmaceutici Business Overview
7.7.3 Chiesi Farmaceutici Budesonide Commercial Medicine Major Product Offerings
7.7.4 Chiesi Farmaceutici Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.7.5 Chiesi Farmaceutici Key News
7.8 Orion Corporation
7.8.1 Orion Corporation Corporate Summary
7.8.2 Orion Corporation Business Overview
7.8.3 Orion Corporation Budesonide Commercial Medicine Major Product Offerings
7.8.4 Orion Corporation Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.8.5 Orion Corporation Key News
7.9 Cipla
7.9.1 Cipla Corporate Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla Budesonide Commercial Medicine Major Product Offerings
7.9.4 Cipla Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.9.5 Cipla Key News
7.10 Synmosa Biopharma
7.10.1 Synmosa Biopharma Corporate Summary
7.10.2 Synmosa Biopharma Business Overview
7.10.3 Synmosa Biopharma Budesonide Commercial Medicine Major Product Offerings
7.10.4 Synmosa Biopharma Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.10.5 Synmosa Biopharma Key News
7.11 Lunan Better Pharma
7.11.1 Lunan Better Pharma Corporate Summary
7.11.2 Lunan Better Pharma Business Overview
7.11.3 Lunan Better Pharma Budesonide Commercial Medicine Major Product Offerings
7.11.4 Lunan Better Pharma Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.11.5 Lunan Better Pharma Key News
7.12 Shanghai Sine Promod
7.12.1 Shanghai Sine Promod Corporate Summary
7.12.2 Shanghai Sine Promod Business Overview
7.12.3 Shanghai Sine Promod Budesonide Commercial Medicine Major Product Offerings
7.12.4 Shanghai Sine Promod Budesonide Commercial Medicine Revenue in Global Market (2017-2022)
7.12.5 Shanghai Sine Promod Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Budesonide Commercial Medicine Market Opportunities & Trends in Global Market
Table 2. Budesonide Commercial Medicine Market Drivers in Global Market
Table 3. Budesonide Commercial Medicine Market Restraints in Global Market
Table 4. Key Players of Budesonide Commercial Medicine in Global Market
Table 5. Top Budesonide Commercial Medicine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Budesonide Commercial Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Budesonide Commercial Medicine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Budesonide Commercial Medicine Product Type
Table 9. List of Global Tier 1 Budesonide Commercial Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Budesonide Commercial Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Budesonide Commercial Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Budesonide Commercial Medicine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Budesonide Commercial Medicine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Budesonide Commercial Medicine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Budesonide Commercial Medicine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Budesonide Commercial Medicine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Budesonide Commercial Medicine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Budesonide Commercial Medicine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Budesonide Commercial Medicine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Budesonide Commercial Medicine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Budesonide Commercial Medicine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Budesonide Commercial Medicine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Budesonide Commercial Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Budesonide Commercial Medicine Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Budesonide Commercial Medicine Product Offerings
Table 32. AstraZeneca Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Budesonide Commercial Medicine Product Offerings
Table 35. Teva Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Corporate Summary
Table 37. Mylan Budesonide Commercial Medicine Product Offerings
Table 38. Mylan Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 39. Sandoz Corporate Summary
Table 40. Sandoz Budesonide Commercial Medicine Product Offerings
Table 41. Sandoz Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 42. Cosmo Pharmaceuticals Corporate Summary
Table 43. Cosmo Pharmaceuticals Budesonide Commercial Medicine Product Offerings
Table 44. Cosmo Pharmaceuticals Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 45. Salix Corporate Summary
Table 46. Salix Budesonide Commercial Medicine Product Offerings
Table 47. Salix Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 48. Chiesi Farmaceutici Corporate Summary
Table 49. Chiesi Farmaceutici Budesonide Commercial Medicine Product Offerings
Table 50. Chiesi Farmaceutici Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 51. Orion Corporation Corporate Summary
Table 52. Orion Corporation Budesonide Commercial Medicine Product Offerings
Table 53. Orion Corporation Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 54. Cipla Corporate Summary
Table 55. Cipla Budesonide Commercial Medicine Product Offerings
Table 56. Cipla Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 57. Synmosa Biopharma Corporate Summary
Table 58. Synmosa Biopharma Budesonide Commercial Medicine Product Offerings
Table 59. Synmosa Biopharma Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 60. Lunan Better Pharma Corporate Summary
Table 61. Lunan Better Pharma Budesonide Commercial Medicine Product Offerings
Table 62. Lunan Better Pharma Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
Table 63. Shanghai Sine Promod Corporate Summary
Table 64. Shanghai Sine Promod Budesonide Commercial Medicine Product Offerings
Table 65. Shanghai Sine Promod Budesonide Commercial Medicine Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Budesonide Commercial Medicine Segment by Type in 2021
Figure 2. Budesonide Commercial Medicine Segment by Application in 2021
Figure 3. Global Budesonide Commercial Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Budesonide Commercial Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Budesonide Commercial Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Budesonide Commercial Medicine Revenue in 2021
Figure 8. By Type - Global Budesonide Commercial Medicine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Budesonide Commercial Medicine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Budesonide Commercial Medicine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Budesonide Commercial Medicine Revenue Market Share, 2017-2028
Figure 12. US Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Budesonide Commercial Medicine Revenue Market Share, 2017-2028
Figure 16. Germany Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 17. France Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Budesonide Commercial Medicine Revenue Market Share, 2017-2028
Figure 24. China Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. India Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Budesonide Commercial Medicine Revenue Market Share, 2017-2028
Figure 30. Brazil Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Budesonide Commercial Medicine Revenue Market Share, 2017-2028
Figure 33. Turkey Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Budesonide Commercial Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sandoz Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Cosmo Pharmaceuticals Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Salix Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Chiesi Farmaceutici Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Orion Corporation Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cipla Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Synmosa Biopharma Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Lunan Better Pharma Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Shanghai Sine Promod Budesonide Commercial Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)